Literature DB >> 23169783

Structural framework of c-Src activation by integrin β3.

Run Xiao1, Xiao-Dong Xi, Zhu Chen, Sai-Juan Chen, Guoyu Meng.   

Abstract

The integrin β3-mediated c-Src priming and activation, via the SH3 domain, is consistently associated with diseases, such as the formation of thrombosis and the migration of tumor cells. Conventionally, activation of c-Src is often induced by the binding of proline-rich sequences to its SH3 domain. Instead, integrin β3 uses R(760)GT(762) for priming and activation. Because of the lack of structural information, it is not clear where RGT will bind to SH3, and under what mechanism this interaction can prime/activate c-Src. In this study, we present a 2.0-Å x-ray crystal structure in which SH3 is complexed with the RGT peptide. The binding site lies in the "N"-Src loop of the SH3 domain. Structure-based site-directed mutagenesis showed that perturbation on the "N"-Src loop disrupts the interaction between the SH3 domain and the RGT peptide. Furthermore, the simulated c-Src:β3 complex based on the crystal structure of SH3:RGT suggests that the binding of the RGT peptide might disrupt the intramolecular interaction between the SH3 and linker domains, leading to the disengagement of Trp260:"C"-helix and further activation of c-Src.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23169783     DOI: 10.1182/blood-2012-07-440644

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Structural insights into the recognition of β3 integrin cytoplasmic tail by the SH3 domain of Src kinase.

Authors:  Priya Katyal; Robbins Puthenveetil; Olga Vinogradova
Journal:  Protein Sci       Date:  2013-09-04       Impact factor: 6.725

2.  Rab34 regulates adhesion, migration, and invasion of breast cancer cells.

Authors:  Lixiang Sun; Xiaohui Xu; Yongjun Chen; Yuxia Zhou; Ran Tan; Hantian Qiu; Liting Jin; Wenyi Zhang; Rong Fan; Wanjin Hong; Tuanlao Wang
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

3.  The Tyrosine Kinase c-Src Specifically Binds to the Active Integrin αIIbβ3 to Initiate Outside-in Signaling in Platelets.

Authors:  Yibing Wu; Lisa M Span; Patrik Nygren; Hua Zhu; David T Moore; Hong Cheng; Heinrich Roder; William F DeGrado; Joel S Bennett
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

4.  Interaction of kindlin-2 with integrin β3 promotes outside-in signaling responses by the αVβ3 vitronectin receptor.

Authors:  Zhongji Liao; Hisashi Kato; Manjula Pandey; Joseph M Cantor; Ararat J Ablooglu; Mark H Ginsberg; Sanford J Shattil
Journal:  Blood       Date:  2015-01-13       Impact factor: 22.113

5.  Expression, purification and preliminary crystallographic studies of the C-terminal SH3 domain of human Tks4.

Authors:  Yuxin Huang; Huolian Qian; Xiaoying Wang; Zhong Cheng; Jixia Ren; Weichen Zhao; Yong Xie
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-02-19       Impact factor: 1.056

Review 6.  SRC-family tyrosine kinases in oogenesis, oocyte maturation and fertilization: an evolutionary perspective.

Authors:  William H Kinsey
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Pro32Pro33 mutations in the integrin β3 PSI domain result in αIIbβ3 priming and enhanced adhesion: reversal of the hypercoagulability phenotype by the Src inhibitor SKI-606.

Authors:  Kendra H Oliver; Tammy Jessen; Emily L Crawford; Chang Y Chung; James S Sutcliffe; Ana M Carneiro
Journal:  Mol Pharmacol       Date:  2014-04-02       Impact factor: 4.436

8.  Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.

Authors:  Wenyi Zhang; Rulu Pan; Mei Lu; Qian Zhang; Ziqi Lin; Yuan Qin; Zhanyu Wang; Siqing Gong; Huan Lin; Shuyi Chong; Liting Lu; Wanqin Liao; Xincheng Lu
Journal:  Oncogene       Date:  2021-09-29       Impact factor: 9.867

9.  Evaluation of targeting c-Src by the RGT-containing peptide as a novel antithrombotic strategy.

Authors:  Jiansong Huang; Xiaofeng Shi; Wenda Xi; Ping Liu; Zhangbiao Long; Xiaodong Xi
Journal:  J Hematol Oncol       Date:  2015-05-30       Impact factor: 17.388

Review 10.  Phagocytic Integrins: Activation and Signaling.

Authors:  Alvaro Torres-Gomez; Carlos Cabañas; Esther M Lafuente
Journal:  Front Immunol       Date:  2020-04-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.